Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon
Thumbnail

Highly touted Alzheimer’s drugs fail to slow cognitive decline

Randall Batemen, MD, principal investigator of the research and a neurologist at Washington University in St. Louis, told the New York Times the results were "really crushing."

NIH division awards $2.5M for PET-based Alzheimer's research

The National Institute on Aging awarded Wake Forest School of Medicine a five-year grant to examine if a novel PET tracer can help researchers tackle the disease.

Thumbnail

‘Game changer’: MRI contrast agent targets new liver cancer biomarker

Initial results were so successful that the material has been fast-tracked by the FDA in an effort to test its accuracy in human clinical trials.

Thumbnail

No gadolinium required: New take on old MRI contrast shows positive results

University of Texas at Dallas researchers applied their novel method to organic radical contrast agents with encouraging conclusions.

Thumbnail

Imaging experts are critical to identifying coronavirus—here’s what to look for

A new special report published in Radiology includes two new case studies of individuals infected with the illness, and details how experts can harness CT to help diagnose 2019-nCoV.

Thumbnail

Brain PET research at critical ‘crossroads,' must move toward collaboration to advance

Nuclear medicine experts called on the field to work together and share data in order to produce the sample sizes needed for further breakthroughs.

Thumbnail

RSNA publishes new coronavirus CT case study

The case details a 33-year-old woman with CT findings commonly seen in other patients with 2019-nCoV.

Thumbnail

FDA approves PET tracer trial testing ability to diagnose multiple sclerosis

The imaging agent—Myeliviz—will be tested in humans for the first time, and may change the way clinicians diagnose the autoimmune disease.

Displaying 2265 - 2272 of 23641

Around the web

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

Cardiovascular Business
Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.